Homocysteine thiolactone
| Names | |
|---|---|
| IUPAC name
(3S)-3-aminothiolan-2-one | |
| Identifiers | |
3D model (JSmol) |
|
| 80591 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| |
| |
| Properties | |
| C4H7NOS | |
| Molar mass | 117.17 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Homocysteine thiolactone (HTL) is an organosulfur compound with the formula H2NCHC(O)SCH2CH2. It is the thiolactone (intramolecular thioester) of homocysteine. It is produced by methionyl-tRNA synthetase in an error-editing reaction that prevents translational incorporation of homocysteine into proteins.
HTL can damage proteins through "homocysteinylation" of protein lysine residues. HTL has been reported to form isopeptide bonds with lysine residues in substrate proteins, a post-translational modification known as N-homocysteinylation (N-Hcy). This causes protein damage via a thiyl radical mechanism. The drugs citiolone and erdosteine are modified versions of homocysteine thiolactone.
When N-Hcy binds α-syn, it exacerbates α-syn aggregation, neurotoxicity, and dopaminergic neuronal degeneration. It also damages the protein DJ-1, contributing to Parkinson's disease.